ACB.TO - Aurora Cannabis Inc.

Toronto - Toronto Delayed Price. Currency in CAD
8.79
-0.13 (-1.46%)
As of 3:28PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close8.92
Open8.91
Bid8.79 x 0
Ask8.80 x 0
Day's Range8.45 - 8.93
52 Week Range5.29 - 16.24
Volume3,345,084
Avg. Volume4,859,181
Market Cap8.901B
Beta (3Y Monthly)2.28
PE Ratio (TTM)N/A
EPS (TTM)-0.25
Earnings DateMay 7, 2019 - May 10, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.79
  • Benzinga5 hours ago

    Cannabis Countdown: Top 10 Marijuana Industry News Stories Of The Week, July 22

    With Thailand’s legalization of medical cannabis in February, some experts predict that other Southeast Asian countries may move to decriminalize the plant. Consultancy Prohibition Partners estimates that Asia’s medicinal cannabis market could by 2024 be worth $5.8 billion. At the end of 2018, Canada, the United States, and Mexico agreed on new terms to replace the North American Free Trade Agreement (NAFTA).

  • Will Aurora, Canopy, Cronos, and Tilray Be Profitable by 2021?
    Motley Fool8 hours ago

    Will Aurora, Canopy, Cronos, and Tilray Be Profitable by 2021?

    Rapid sales growth yields no guarantee of profitability in the cannabis space.

  • The Absurdity of Aurora Cannabis' Latest Analyst Downgrade
    Motley Foolyesterday

    The Absurdity of Aurora Cannabis' Latest Analyst Downgrade

    One top analyst isn't as bullish about this top pot stock as he was just three months ago. And it makes no sense.

  • Aurora Cannabis weighs on sector after BofA downgrade highlights its cash burn
    MarketWatch2 days ago

    Aurora Cannabis weighs on sector after BofA downgrade highlights its cash burn

    Aurora Cannabis shares tumble Thursday to pull the overall sector lower, after an analyst at Bank of America Merrill Lynch downgraded the stock on concerns about its rate of spending cash.

  • Weekly Cannabis Stock News: Curaleaf Makes a Power Play
    Motley Fool2 days ago

    Weekly Cannabis Stock News: Curaleaf Makes a Power Play

    Curaleaf is buying expansion with its $875 acquisition of Grassroots. Meanwhile, OrganiGram reported Q3 results, and Aurora Cannabis had a good news/bad news week.

  • Analyst Downgrade Weighs on Aurora Cannabis Stock
    Motley Fool2 days ago

    Analyst Downgrade Weighs on Aurora Cannabis Stock

    Merrill Lynch's recommendation cut is affecting investor sentiment on the company.

  • Aurora Cannabis Falls As Analysts Warn Of Cash Woes; Marijuana Stocks Follow
    Investor's Business Daily4 days ago

    Aurora Cannabis Falls As Analysts Warn Of Cash Woes; Marijuana Stocks Follow

    Aurora Cannabis is burning through cash, prompting a BofA downgrade. Aurora Cannabis fell along with other marijuana stocks.

  • Aurora Cannabis Stock Falls on Bank of America Downgrade
    Market Realist4 days ago

    Aurora Cannabis Stock Falls on Bank of America Downgrade

    On Thursday, Bank of America downgraded Aurora Cannabis stock (ACB) to “neutral” from its previous “buy” rating. Here's why.

  • Aurora Cannabis Stock Gets Downgraded
    Motley Fool4 days ago

    Aurora Cannabis Stock Gets Downgraded

    Analysts fear the marijuana company is burning through cash.

  • Curaleaf's Plan To Become No. 1 in Cannabis
    Investopedia4 days ago

    Curaleaf's Plan To Become No. 1 in Cannabis

    Curaleaf's acquisitions are dramatically expanding its footprint to exploit the market's exploding growth.

  • Stock Market News: Aurora Gets Burned; IBM Gets Over the Blues
    Motley Fool4 days ago

    Stock Market News: Aurora Gets Burned; IBM Gets Over the Blues

    The summer doldrums continued on Wall Street despite many companies reporting earnings.

  • Benzinga4 days ago

    Bank Of America Downgrades Aurora Cannabis, Concerned About Cash Burn

    Aurora could be considered "among the best" cannabis companies and similar to its peers, Aurora is bleeding out cash, Carey wrote in the note. Aurora's cash position is "less robust" compared to its peers and is on track to turn negative as early as the first quarter 2020.

  • MarketWatch4 days ago

    Aurora Cannabis shares slide after BofA downgrade on concerns about cash burn

    Aurora Cannabis Inc. shares fell 2.3% in early trade Thursday, after BofA Merrill Lynch downgraded the stock to neutral from buy and lowered its stock price target to $8 from $10, on concerns about the company's cash burn. "Aurora has emerged as one of the best operators in the cannabis sector, with industry leading scale and margins even vs other large peers, and global optionality," analyst Christopher Carey wrote in a note to clients. "However, despite this, and a focus on profit, (CQ2 positive EBITDA target), it is burning cash and by our estimates could be cash negative by CQ120 (absent financing), namely if a large convertible debenture due in CQ120 stays out of the money." Even if its current cash burn were to improve, Aurora will likely need funding in the next few quarters," said the analyst The company has access to about C$100 million in a credit facility, but a convertible note that matures in the first quarter of 2020 will likely need to be paid in cash, he wrote. Shares have gained 47% in 2019, while the S&P 500 has gained 19%.

  • Benzinga4 days ago

    Italy Chooses Aurora Cannabis To Supply Medical Marijuana

    Aurora Cannabis Inc. (NYSE: ACB) announced Thursday it has won the Italian government’s public tender to supply medical marijuana in Italy. Aurora Cannabis was the only company to meet the demanding requirements of the tender, with the Italian cannabis market being one of the most strictly regulated in the world. Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 -- Click here to learn more!

  • Why Is the US CBD Market So Attractive?
    Market Realist4 days ago

    Why Is the US CBD Market So Attractive?

    Brightfield Group estimates that the CBD market could hit about $23.7 billion by 2023. However, regulatory hurdles could impact the US market.

  • CNW Group4 days ago

    High Tide Announces Research Analyst Coverage by Canaccord Genuity

    High Tide Announces Research Analyst Coverage by Canaccord Genuity

  • Reuters4 days ago

    UPDATE 1-Aurora Cannabis wins contract to supply medical cannabis to Italy

    Canadian pot producer Aurora Cannabis Inc said on Thursday it had secured a two-year contract to supply medical cannabis to the Italian government. The company will supply a minimum of 400 kg of medical cannabis to the country, one of the most strictly regulated medical cannabis markets in the world. Aurora said it will supply cannabis from its Canadian EU GMP certified facilities and imported into Italy through Aurora Deutschland, its wholly-owned European unit.

  • Cannabis stocks led higher by Curaleaf after company buys Chicago-based multistate operator
    MarketWatch4 days ago

    Cannabis stocks led higher by Curaleaf after company buys Chicago-based multistate operator

    Cannabis stocks were mostly higher Wednesday, with Curaleaf leading the pack after announcing an $875 million stock-and-cash deal that will help it expand into new states, including Illinois.

  • Aurora Cannabis Selected as Sole Winner in Italian Cannabis Tender
    CNW Group4 days ago

    Aurora Cannabis Selected as Sole Winner in Italian Cannabis Tender

    EDMONTON , July 18, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (ACB) (ACB), the Canadian company defining the future of cannabis worldwide, announced today that the Company has been selected as the only winner of the Italian government's public tender to supply medical cannabis in Italy . The supply contract is expected to be signed in September 2019 .

  • GlobeNewswire5 days ago

    Apolo II Acquisition Corp. Signs Definitive Agreement With Terrace Inc. to Advance Qualifying Transaction

    Apolo II Acquisition Corp. (the “Corporation”), a “capital pool company” pursuant to the policies of the TSX Venture Exchange (the “Exchange”), is pleased to announce that it has entered into a definitive business combination agreement (the “Definitive Agreement”) dated July 17, 2019 with Terrace Inc. (“Terrace”) and Terrance Acquisition Corp. (a wholly-owned subsidiary of the Corporation) (“Subco”) in furtherance of the Corporation’s previously announced proposed Qualifying Transaction (as such term is defined in Policy 2.4 – Capital Pool Companies of the Exchange’s Corporate Finance Manual (the “Manual”)) (the “Proposed Transaction”). Terrace was incorporated pursuant to the provisions of the Business Corporations Act (Ontario) (the “OBCA”) on August 28, 2018.

  • TheStreet.com5 days ago

    [video]Ladenburg Analysts Spark Coverage of Cannabis Stocks Canopy, Aurora and Tilray

    Ladenburg Thalmann initiated coverage of the cannabis sector, with preference for companies focused on long-term value creation.

  • Cannabis Outlook From OrganiGram’s Earnings Report
    Market Realist6 days ago

    Cannabis Outlook From OrganiGram’s Earnings Report

    On Monday, OrganiGram (OGI) reported its third-quarter earnings. Following the company's earnings, we reported how it performed in the third quarter. To learn more, read OrganiGram’s Third-Quarter Earnings. Interestingly, OrganiGram stressed that the growth would be heavily driven by retail stores opening in Ontario and Quebec. The company stated that legalizing edibles and derivative products […]

  • 7 Reasons Aurora, Canopy, Cronos, and HEXO Are All At or Near 6-Month Lows
    Motley Fool6 days ago

    7 Reasons Aurora, Canopy, Cronos, and HEXO Are All At or Near 6-Month Lows

    The buzz is beginning to wear off for the most popular cannabis stocks.

  • Marijuana Stocks Rise Despite Organigram Loss; Aurora Cannabis Lands Cultivation Licenses
    Investor's Business Daily7 days ago

    Marijuana Stocks Rise Despite Organigram Loss; Aurora Cannabis Lands Cultivation Licenses

    Organigram earnings missed Q3 views. Aurora Cannabis got two new cultivation licenses. Organigram, Aurora and other marijuana stocks rose.